AscellaHealth

Based in Berwyn, Pennsylvania, with offices throughout the U.S. and Europe, AscellaHealth is a leading provider in the Specialty Pharmacy and Healthcare services industry. The company delivers a wide array of specialized, technology-driven pharmaceutical and medical management services tailored to the needs of payers, providers, life sciences companies, and patients. The company is distinguished by its innovative, patient-first approach, utilizing proprietary technology to develop programs and services that improve health outcomes and the quality of life for patients with complex, chronic conditions or rare diseases that require specialty medications, including gene and cell therapies.

Dea Belazi, Chief Executive Officer (CEO) & Co-founder of AscellaHealth, has been instrumental in the company's evolution into a globally recognized Healthcare & Specialty Pharmacy (S.P.) solutions provider. With a team of over 200 professionals serving stakeholders worldwide, the company delivers customized, technology-enhanced solutions that improve access to medications and patient outcomes for those dealing with specialty conditions or rare diseases. Belazi, a seasoned business executive with clinical expertise as a Registered Pharmacist, strategically designs its extensive suite of services to support the unique needs of pharmaceutical manufacturers launching complex specialty or rare disease products.

Bill Oldham, Chairman, President, and Co-founder, has brought his extensive fintech experience into the pharmacy benefit management (PBM) sector, driving AscellaHealth to become a leader in the Specialty Pharmacy field. Under his leadership, the company achieved a remarkable 1556% revenue growth over four years through strategic organic growth and acquisitions. Oldham's contributions have been recognized with several awards, including Philadelphia Business Journal's 2022 CFO of the Year and being named a Philadelphia Titan 100 for 2023 and 2024.

About AscellaHealth: Better Data for Better Health

AscellaHealth's holistic approach combines clinical, financial, and technological capabilities to facilitate more accessible access to specialty medications, thus improving clinical outcomes and enriching the therapy experience for patients. Its comprehensive services cover all aspects of specialty disease management, including Pre-Commercialization and Market Access Solutions, Hub and Patient Support, Limited Distribution Drug Strategies, Proprietary Specialty Pharmacy and Infusion Network, Customized Clinical Programs, Technology-based Patient Engagement, Medical and Pharmacy Benefit Management, Drug Rebate Programs, and Real-Time Prescription Data and Analytics via its advanced technology platform.

AscellaHealth's Solutions

Life Sciences

AscellaHealth serves as a crucial launch partner for life sciences companies tackling the market challenges of commercializing treatments for complex, chronic conditions. It offers a full range of support from clinical trials to patient product transitions, including essential services like distribution, patient support, and comprehensive data analysis.

Payers & Health Plans

AscellaHealth equips captives, self-insured entities, at-risk providers, PBMs, and regional health plans with a broad suite of services designed to optimize patient outcomes and manage costs. The company specializes in specialty and medical cost management, formulary and network design, custom clinical programs, and comprehensive data analysis.

AscellaHealth's Innovation Is Widely Recognized

As a recognized leader in global specialty pharmacy and healthcare services, AscellaHealth has earned multiple accolades for its innovative solutions, including the 2024 Top 10 Pharma & Life Science Solutions Providers and Health Tech Outlook's 2024 Top Pharmacy Management Solutions Provider.

About Dea Belazi

Dea Belazi, co-founder of AscellaHealth, has guided the company through significant growth, securing numerous industry awards like The Financial Times Fastest Growing Company and Deloitte Fast 500. Belize is an active member of the Philadelphia business community, acknowledged with distinctions such as EY Entrepreneur of The Year® National Finalist and Titan 100. His academic credentials include a PharmD from the University of Rhode Island, a Master of Public Health from Johns Hopkins University, and a post-doctoral fellowship in health outcomes research at Thomas Jefferson University.

About Bill Oldham

Bill Oldham's extensive career as an entrepreneur, investor, and consultant across health, technology, financial, and energy sectors has fostered the development of innovative and dynamic companies. His experience with fintech in the PBM industry and leadership in building two $100-million companies underscore his impact on global business practices. Oldham began his career in financial services on Wall Street and has since demonstrated a profound understanding of global market dynamics and their implications for businesses. He holds an MBA from Manchester Business School with a focus on entrepreneurship and venture finance and a certification in Blockchain Technologies from MIT Sloan School of Management.